Literature DB >> 29788392

Prognostic accuracy of different lymph node staging systems in rectal adenocarcinoma with or without preoperative radiation therapy.

Feng Shen1, Junhui Cui1, Ke Cai1, Haiqiang Pan1, Heqi Bu1, Feng Yu1.   

Abstract

BACKGROUND AND
OBJECTIVE: A variety of different lymph node (LN) staging systems have been developed to describe the lymph node status accurately. We aim to compare the prognostic accuracy of American Joint Committee on Cancer seventh N stage relative to negative number of lymph node (nLN), lymph node ratio (LNR) and log odds of metastatic lymph nodes (LODDS) in rectal adenocarcinoma (RC).
METHODS: A total of 19 167 Stage II-III rectal cancer patients who underwent surgical resection of rectal adenocarcinoma were identified from Surveillance, Epidemiology and End Results database. Akaike's Information Criterion (AIC) and the Harrell's concordance index (c statistic) were used to evaluate the relative discriminative power of the different LN staging systems.
RESULTS: Of the 19 167 patients, 10 958 received preoperative radiotherapy (pre-RT cohort) and 8209 patients were treated with surgical resection directly (SURG cohort). When assessed using categorical cutoff values, LNR has a somewhat better prognostic accuracy both in pre-RT (c-index: 0.62; AIC: 2988.6) and SURG groups (c-index: 0.60; AIC: 3359.8). Further analysis based on different total number of lymph node (TNLN) suggested that when less than 10 lymph nodes were retrieved, LNR exhibited significant superiority (pre-RT: c-index: 0.597, AIC: 1006.8; SURG: c-index: 0.560, AIC: 810.5). When analyzed as a continuous variable, the LODDS system performed the best and was not impacted by TNLN.
CONCLUSION: When assessed as a categorical variable, LNR was the most powerful method to predict survival for Stage II-III RC patients with limited TNLN. Rather, LODDS was the most accurate staging system regardless of the TNLN when LN status was modeled as continuous variable.

Entities:  

Mesh:

Year:  2018        PMID: 29788392     DOI: 10.1093/jjco/hyy070

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  5 in total

1.  A prognostic nomogram for stage II/III rectal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgical resection.

Authors:  Yanfei Lin
Journal:  BMC Surg       Date:  2022-07-04       Impact factor: 2.030

2.  Comparison of Different Lymph Node Staging Systems in Patients With Resectable Colorectal Cancer.

Authors:  Jun-Peng Pei; Chun-Dong Zhang; Yu-Chen Fan; Dong-Qiu Dai
Journal:  Front Oncol       Date:  2019-01-15       Impact factor: 6.244

3.  Log odds of positive lymph nodes as a novel prognostic predictor for colorectal cancer: a systematic review and meta-analysis.

Authors:  Yiding Li; Guiling Wu; Yujie Zhang; Ben Han; Wanli Yang; Xiaoqian Wang; Lili Duan; Liaoran Niu; Junfeng Chen; Wei Zhou; Jinqiang Liu; Daiming Fan; Liu Hong
Journal:  BMC Cancer       Date:  2022-03-18       Impact factor: 4.430

4.  Construction of a new clinical staging system for colorectal cancer based on the lymph node ratio: A validation study.

Authors:  Yan Yang; Yawei Wang; Zhengbin Wang
Journal:  Front Surg       Date:  2022-08-25

5.  Lymph node status and its impact on the prognosis of left-sided and right-sided colon cancer: A SEER population-based study.

Authors:  Yadi Huang; Linlin Ji; Jialong Zhu; Xiaobei Mao; Siqi Sheng; Shuai Hao; Dan Xiang; Jiani Guo; Gongbo Fu; Mengxi Huang; Zengjie Lei; Xiaoyuan Chu
Journal:  Cancer Med       Date:  2021-10-26       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.